Feifei Sun
Impact in
-
- Cancer-related molecular mechanisms research
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 2
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Bo Han (13 shared papers)Jing Hu (12 shared papers)Xueting Xiong (6 shared papers)Tingting Feng (6 shared papers)Xuesen Dong (3 shared papers)Wenbo Zhang (4 shared papers)Xin Wang (2 shared papers)Weiwen Chen (4 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Oncogene (2 papers)Neoplasia (2 papers)Nature Communications (1 paper)BMC Medicine (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Feifei Sun
23 papers receiving 334 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 67
- Molecular Biology 175
- Cell Biology 33
- Pulmonary and Respiratory Medicine 49
- Biomaterials 22
Countries citing papers authored by Feifei Sun
This map shows the geographic impact of Feifei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Sun more than expected).
Fields of papers citing papers by Feifei Sun
This network shows the impact of papers produced by Feifei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Sun. The network helps show where Feifei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 60 | |
| 2 | 2019 | 47 | |
| 3 | 2022 | 30 | |
| 4 | 2019 | 29 | |
| 5 | 2019 | 27 | |
| 6 | 2013 | 26 | |
| 7 | 2022 | 19 | |
| 8 | Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis. | 2017 | 11 |
| 9 | 2020 | 11 | |
| 10 | 2017 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2019 | 9 | |
| 13 | Detection of gene copy number alterations in DCIS and invasive breast cancer by QM-FISH. | 2016 | 8 |
| 14 | 2023 | 8 | |
| 15 | 2025 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2023 | 5 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 2 |
About Feifei Sun
Feifei Sun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Cell Biology, having authored 26 papers that have together received 339 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Cancer Genomics and Diagnostics (2 papers), Protein Degradation and Inhibitors (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Cancer Research (67 citations), Molecular Biology (175 citations), Cell Biology (33 citations), Pulmonary and Respiratory Medicine (49 citations) and Biomaterials (22 citations). Feifei Sun has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Bo Han, Jing Hu, Xueting Xiong, Tingting Feng, Xuesen Dong, Wenbo Zhang, Xin Wang, Weiwen Chen, Xueli Wang and Benkang Shi. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Oncogene, Neoplasia, Nature Communications and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.